Proscia has entered into a definitive agreement to be acquired by @Agilent. For over a decade, our mission has been to rewire pathology for precision medicine. Joining Agilent brings the scale and resources to deliver on that mission faster, for the same customers and team that got us here. Read more here: proscia.com/press-release/ag…

When SpecialtyVETPATH’s ocular pathologist needed to relocate to Massachusetts for family reasons, remote collaboration went from a nice-to-have to a mission-critical priority. There was just one catch: Dr. Jennifer Ward, DVM, CEO and Co-Laboratory Director, had no IT background and no in-house IT team to help her with the transition. Instead of backing down, Dr. Ward took on the learning curve herself. She tapped into her network across academia and human pathology and led her lab through the complexities of going digital. Hear more stories in our Feats of Strength series: info.proscia.com/feats-of-st…

“Epic-native” is often used loosely, but for health systems and academic medical centers running Epic Beaker, the distinction matters. Swipe through to see what “Epic-native” digital pathology really means, and read the full breakdown from our Senior Integration Manager, Jacob Blaylock, here: proscia.com/blog/maximizing-…

For over a decade, our mission has been to rewire pathology for precision medicine. Since we shared our vision, change across diagnostic laboratories and life sciences organizations has only sped up. There’s still a lot of work ahead to make precision medicine the standard, but the beliefs behind that future remain the same. Revisit our full vision here: proscia.com/blog/rewiring-pa…

ICYMI: Last week at SREcon EMEA 2026 in Dublin, Kyriakos Toulgaridis and Jeff Rhude shared how we changed our observability story with ClickHouse, OpenTelemetry, and a different approach to the problem. A big thank you to everyone who attended the talk!

Concentriq serves more than 4,000 laboratories, hospitals, and clinics, and has powered 30,000+ studies from discovery to trials. Stop by booth 306 to see our platform and meet the team behind it. At 2:30 PM, users from Cleveland Clinic will join us to share their experience.

See you tonight, #PathVisions26!

Our CEO @davidwest_irl shared his thoughts on our recent news. Read more below. linkedin.com/pulse/next-chap…

Kary Rogers spent more than 15 years leading enterprise support at networking and security companies, where a product failure means nobody works. That is where he learned what mission-critical means. At Proscia, the stakes carry a different weight. Our customers’ work informs a diagnosis with real impact on patients and their loved ones, shaping how we build and support our product. Hear from Kary, our Vice President of Global Support, in the clip below and read the full conversation: proscia.com/blog/getting-to-…

Companion diagnostic programs rarely follow a fixed path. Biomarkers evolve, new algorithms emerge, and the partners or technologies needed later in development may look very different from those needed at the start. The architecture supporting those programs should leave room for that evolution. At Biomarkers, CDx & Precision Medicine Europe, Labcorp's Dr. Paul Mesange will share how an open approach with our Concentriq platform can support biomarker discovery and CDx development from early exploratory work through late-phase bridging studies, without requiring sponsors to commit to a closed technology ecosystem before a program's viability is known. Join his session on October 13 at 15:20 in Conference Room 9, then visit the Proscia team at Stand 69.

Congratulations to all of the leaders recognized on The Pathologist’s 2026 Power List. Among them, it was great to see see our customers Dr. Derrick Forchetti of South Bend Medical Foundation and Dr. Sajjad Malik of HNL Lab Medicine. Their work reflects the leadership, impact, and commitment helping move pathology and laboratory medicine forward. Explore the full 2026 Power List below. thepathologist.com/issues/20…

Before you cash out of CAP26, stop by Booth 118. It is the final day of exhibits at CAP26 and your last chance to catch our team in person this week. Stop by to see Concentriq and discuss your digital pathology goals. See you on the floor.

CAP26 is in full swing, and we're betting big that you'll enjoy seeing why Concentriq is the platform that pathologists love. Today at 10:15 AM, join Rebecca Ford and Sarah Eysoldt in the Product Theater for a look at how Concentriq pairs the feel of glass with the intelligence of AI, helping you to meet your caseloads with speed and confidence. Then, stop by our booth 118 or book a time to explore the pathology AI platform for yourself. info.proscia.com/cap-2026

As Childhood Cancer Awareness Month comes to a close, we’re reminded of the estimated 400,000 children and adolescents around the world who develop cancer each year. We recognize the children and young people facing cancer, whose courage and resilience continue to inspire us. We’re also grateful for the extraordinary community surrounding them: physicians, nurses, pathologists, researchers, pharmacists, laboratory professionals, social workers, child life specialists, caregivers, families, and so many others. Thank you to everyone who dedicates their expertise, compassion, and care to children with cancer.

We’re bringing the Fifth Generation of Concentriq to CAP26 and are ready to show you why it's the pathology AI platform pathologists want to work in, operations teams can scale, and leaders can build around. Stop by Booth 118, and on Sunday, October 4 from 10:15–11:15 AM, join us for our Product Theater. Book a meeting with us at CAP: info.proscia.com/cap-2026